Global Spatial Transcriptomic Technology Market Research Report 2024

Publication ID:

PB512243108

Publication Date:

December 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Spatial Transcriptomic Technology was valued at US$ 1749 million in the year 2023 and is projected to reach a revised size of US$ 3859 million by 2030, growing at a CAGR of 11.8% during the forecast period.
Spatial Transcriptomic Technology is a cutting-edge technology that combines gene expression analysis and tissue spatial structure, aiming to obtain gene expression information in different regions on tissue sections.While single-cell RNA sequencing (scRNA-seq) has made significant strides in inferring cell types and differentiation trajectories, particularly in developmental biology studies, it grapples with the challenge of preserving spatial information once cells are dissociated in suspension. Recent advancements in high-throughput spatial transcriptome technology have addressed this issue by propelling the study of the transcriptome to a third stage. This technology enables simultaneous acquisition of gene expression profiles and spatial distribution locations at the tissue in situ level, thereby enhancing the understanding of real gene expression in cells at the spatial level.The existing research technologies mainly include 10x Genomics Visium (two methods based on poly-A and probe), DynaSpatial, HDST, BMKMANU S1000, Slide-seq V2, Curio Seeker (commercial version of Slide-seq), Slide-tag, Stereo-seq, PIXEL-seq, Salus and DBiT-seq.
North American market for Spatial Transcriptomic Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Spatial Transcriptomic Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Spatial Transcriptomic Technology in Pathology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Spatial Transcriptomic Technology include 10x Genomics, NanoString, Dynamic-biosystems, Curio Bioscience, BGI Genomics, Laboratory of Computational Biology, Salus BioMed, AtlasXomics Inc., uwGuLab, Vizgen Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Spatial Transcriptomic Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spatial Transcriptomic Technology.
The Spatial Transcriptomic Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Spatial Transcriptomic Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spatial Transcriptomic Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
NanoString
Dynamic-biosystems
Curio Bioscience
BGI Genomics
Laboratory of Computational Biology
Salus BioMed
AtlasXomics Inc.
uwGuLab
Vizgen Inc
Segment by Type
Spatial Transcriptome Technology Leveraging In Situ Capture
Spatial Transcriptome Technology Based on In Situ Hybridization
Other
Segment by Application
Pathology
Immunology
Developmental Biology
Oncology
Neuroscience
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spatial Transcriptomic Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spatial Transcriptomic Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Spatial Transcriptome Technology Leveraging In Situ Capture
1.2.3 Spatial Transcriptome Technology Based on In Situ Hybridization
1.2.4 Other
1.3 Market by Application
1.3.1 Global Spatial Transcriptomic Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pathology
1.3.3 Immunology
1.3.4 Developmental Biology
1.3.5 Oncology
1.3.6 Neuroscience
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spatial Transcriptomic Technology Market Perspective (2019-2030)
2.2 Global Spatial Transcriptomic Technology Growth Trends by Region
2.2.1 Global Spatial Transcriptomic Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Spatial Transcriptomic Technology Historic Market Size by Region (2019-2024)
2.2.3 Spatial Transcriptomic Technology Forecasted Market Size by Region (2025-2030)
2.3 Spatial Transcriptomic Technology Market Dynamics
2.3.1 Spatial Transcriptomic Technology Industry Trends
2.3.2 Spatial Transcriptomic Technology Market Drivers
2.3.3 Spatial Transcriptomic Technology Market Challenges
2.3.4 Spatial Transcriptomic Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spatial Transcriptomic Technology Players by Revenue
3.1.1 Global Top Spatial Transcriptomic Technology Players by Revenue (2019-2024)
3.1.2 Global Spatial Transcriptomic Technology Revenue Market Share by Players (2019-2024)
3.2 Global Spatial Transcriptomic Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Spatial Transcriptomic Technology Revenue
3.4 Global Spatial Transcriptomic Technology Market Concentration Ratio
3.4.1 Global Spatial Transcriptomic Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spatial Transcriptomic Technology Revenue in 2023
3.5 Global Key Players of Spatial Transcriptomic Technology Head office and Area Served
3.6 Global Key Players of Spatial Transcriptomic Technology, Product and Application
3.7 Global Key Players of Spatial Transcriptomic Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Spatial Transcriptomic Technology Breakdown Data by Type
4.1 Global Spatial Transcriptomic Technology Historic Market Size by Type (2019-2024)
4.2 Global Spatial Transcriptomic Technology Forecasted Market Size by Type (2025-2030)
5 Spatial Transcriptomic Technology Breakdown Data by Application
5.1 Global Spatial Transcriptomic Technology Historic Market Size by Application (2019-2024)
5.2 Global Spatial Transcriptomic Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Spatial Transcriptomic Technology Market Size (2019-2030)
6.2 North America Spatial Transcriptomic Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Spatial Transcriptomic Technology Market Size by Country (2019-2024)
6.4 North America Spatial Transcriptomic Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spatial Transcriptomic Technology Market Size (2019-2030)
7.2 Europe Spatial Transcriptomic Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Spatial Transcriptomic Technology Market Size by Country (2019-2024)
7.4 Europe Spatial Transcriptomic Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spatial Transcriptomic Technology Market Size (2019-2030)
8.2 Asia-Pacific Spatial Transcriptomic Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Spatial Transcriptomic Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific Spatial Transcriptomic Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spatial Transcriptomic Technology Market Size (2019-2030)
9.2 Latin America Spatial Transcriptomic Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Spatial Transcriptomic Technology Market Size by Country (2019-2024)
9.4 Latin America Spatial Transcriptomic Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spatial Transcriptomic Technology Market Size (2019-2030)
10.2 Middle East & Africa Spatial Transcriptomic Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Spatial Transcriptomic Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa Spatial Transcriptomic Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Details
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Spatial Transcriptomic Technology Introduction
11.1.4 10x Genomics Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.1.5 10x Genomics Recent Development
11.2 NanoString
11.2.1 NanoString Company Details
11.2.2 NanoString Business Overview
11.2.3 NanoString Spatial Transcriptomic Technology Introduction
11.2.4 NanoString Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.2.5 NanoString Recent Development
11.3 Dynamic-biosystems
11.3.1 Dynamic-biosystems Company Details
11.3.2 Dynamic-biosystems Business Overview
11.3.3 Dynamic-biosystems Spatial Transcriptomic Technology Introduction
11.3.4 Dynamic-biosystems Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.3.5 Dynamic-biosystems Recent Development
11.4 Curio Bioscience
11.4.1 Curio Bioscience Company Details
11.4.2 Curio Bioscience Business Overview
11.4.3 Curio Bioscience Spatial Transcriptomic Technology Introduction
11.4.4 Curio Bioscience Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.4.5 Curio Bioscience Recent Development
11.5 BGI Genomics
11.5.1 BGI Genomics Company Details
11.5.2 BGI Genomics Business Overview
11.5.3 BGI Genomics Spatial Transcriptomic Technology Introduction
11.5.4 BGI Genomics Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.5.5 BGI Genomics Recent Development
11.6 Laboratory of Computational Biology
11.6.1 Laboratory of Computational Biology Company Details
11.6.2 Laboratory of Computational Biology Business Overview
11.6.3 Laboratory of Computational Biology Spatial Transcriptomic Technology Introduction
11.6.4 Laboratory of Computational Biology Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.6.5 Laboratory of Computational Biology Recent Development
11.7 Salus BioMed
11.7.1 Salus BioMed Company Details
11.7.2 Salus BioMed Business Overview
11.7.3 Salus BioMed Spatial Transcriptomic Technology Introduction
11.7.4 Salus BioMed Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.7.5 Salus BioMed Recent Development
11.8 AtlasXomics Inc.
11.8.1 AtlasXomics Inc. Company Details
11.8.2 AtlasXomics Inc. Business Overview
11.8.3 AtlasXomics Inc. Spatial Transcriptomic Technology Introduction
11.8.4 AtlasXomics Inc. Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.8.5 AtlasXomics Inc. Recent Development
11.9 uwGuLab
11.9.1 uwGuLab Company Details
11.9.2 uwGuLab Business Overview
11.9.3 uwGuLab Spatial Transcriptomic Technology Introduction
11.9.4 uwGuLab Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.9.5 uwGuLab Recent Development
11.10 Vizgen Inc
11.10.1 Vizgen Inc Company Details
11.10.2 Vizgen Inc Business Overview
11.10.3 Vizgen Inc Spatial Transcriptomic Technology Introduction
11.10.4 Vizgen Inc Revenue in Spatial Transcriptomic Technology Business (2019-2024)
11.10.5 Vizgen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

10x Genomics
NanoString
Dynamic-biosystems
Curio Bioscience
BGI Genomics
Laboratory of Computational Biology
Salus BioMed
AtlasXomics Inc.
uwGuLab
Vizgen Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂